- Trials with a EudraCT protocol (18)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
18 result(s) found for: Hysteroscopy.
Displaying page 1 of 1.
EudraCT Number: 2021-001182-21 | Sponsor Protocol Number: APC-01-2021 | Start Date*: 2021-06-21 | |||||||||||
Sponsor Name:University Hospital Puerta de Hierro Majadahonda, Madrid, Spain | |||||||||||||
Full Title: RANDOMIZED, UNICENTRIC, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL TO ASSESS THE EFFICACY OF PARACERVICAL ANESTHESIA FOR PAIN CONTROL DURING AN OFFICE HYSTEROSCOPY | |||||||||||||
Medical condition: Need to do an office Hysteroscopy for any reason | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001020-19 | Sponsor Protocol Number: NL65360.18 | Start Date*: 2019-04-05 |
Sponsor Name:Ghent University Hospital | ||
Full Title: Nifedipine induced pain relief during hysteroscopy | ||
Medical condition: Pain intensity during hysteroscopy | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002051-13 | Sponsor Protocol Number: PANN3006 | Start Date*: 2005-08-17 |
Sponsor Name:Imperial College, London | ||
Full Title: A randomised double-blind placebo-controlled trial of oral misoprostol for cervical priming before outpatient hysteroscopy | ||
Medical condition: Abnormal uterine bleeding (hysteroscopy to investigate and treatment of abnormal uterine bleeding) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2009-011775-78 | Sponsor Protocol Number: 08GINE1 | Start Date*: 2009-01-20 |
Sponsor Name:UNIVERSITA` CAMPUS BIOMEDICO | ||
Full Title: Evaluation of efficacy of antibiotic prophylaxis in patients undergoing operative hysteroscopy | ||
Medical condition: Patients needing operative hysteroscopy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001775-20 | Sponsor Protocol Number: PH-HYS-01 | Start Date*: 2013-06-07 | |||||||||||
Sponsor Name:Pharmanest AB | |||||||||||||
Full Title: A phase 2 study investigating the feasibility of using a topical formulation of lidocaine (SHACT) for hysteroscopy in women. | |||||||||||||
Medical condition: Investigating the feasibility of using a topical formulation. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005426-30 | Sponsor Protocol Number: HISTEROSCOPIA-2013 | Start Date*: 2014-04-10 |
Sponsor Name:FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS | ||
Full Title: USE OF NITROUS OXIDE FOR PAIN RELIEF IN DIFFERENT HISTEROSCOPY PROCEDURES | ||
Medical condition: Pain associated to hysteroscopy procedures | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001201-28 | Sponsor Protocol Number: 2006-02-27UUS | Start Date*: Information not available in EudraCT |
Sponsor Name:Department of Gynaecology, Helse Finnmark, Klinikk Hammerfest | ||
Full Title: Self-administered vaginal misoprostol at home for cervical ripening prior to outpatient hysteroscopy: a randomised placebo-controlled trial. | ||
Medical condition: Intrauterine pathology | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005160-23 | Sponsor Protocol Number: 2013 | Start Date*: 2013-05-02 |
Sponsor Name:VU medical center | ||
Full Title: Hismys study. Misoprostol for cervical priming prior to hysteroscopy in postmenopausal and nulliparous premenopausal women; a multi-centre randomised placebo controlled trial | ||
Medical condition: Reduction of pain during hysteroscopy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003358-15 | Sponsor Protocol Number: 2014-003358-15 | Start Date*: 2015-05-29 |
Sponsor Name:James Martin Shannon, MB Bch NUI | ||
Full Title: Intraoperative use of dexamethasone in day-case gynaecological surgery and its impact on sleep quality in the postoperative period. | ||
Medical condition: Postoperative sleep quality | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: IE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002823-34 | Sponsor Protocol Number: 27818 | Start Date*: 2007-11-08 | |||||||||||
Sponsor Name:Merck Serono International S.A | |||||||||||||
Full Title: A phase II, multicentre, randomised, assessor.blinded, active-comparator, parallel-group dose finding trial to evaluate AS900672-Enriched versus follitropin alfa (GONAL-f) in oligo-anovulatory infe... | |||||||||||||
Medical condition: oligoanovulatory infertile women who are candidates for ovulation induction (OI) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) FR (Completed) DE (Prematurely Ended) IT (Prematurely Ended) ES (Completed) DK (Completed) BE (Completed) NL (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005420-42 | Sponsor Protocol Number: S55983 | Start Date*: 2014-02-06 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Is postoperative IUI better than expectant management in infertile endometriosis patients with good prognosis based on EFI score? | ||||||||||||||||||
Medical condition: (Sub)Fertility in endometriosis after laparoscopic removal of the endometriosos lesions: an RCT comparing intra-uterine insemination with expectant management | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001708-39 | Sponsor Protocol Number: S54224 | Start Date*: 2012-06-07 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Prospective randomized trial concerning three different stimulation methods in IVF/ICSI treatment in poor responders | ||||||||||||||||||
Medical condition: Subfertility | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-001830-32 | Sponsor Protocol Number: RC31/17/0448 | Start Date*: 2019-12-18 |
Sponsor Name:University Hospital Toulouse | ||
Full Title: Phase III Trial to assess impact of ultra-long versus long down-regulation protocol on IVF/ICSI outcomes in infertile women presenting with adenomyosis. | ||
Medical condition: Infertilty in women with adenomyosis. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-003975-23 | Sponsor Protocol Number: IGX1-ENT-XS-16-01 | Start Date*: 2020-04-20 | |||||||||||
Sponsor Name:Asherman Therapy S.L.U. | |||||||||||||
Full Title: Efficacy and safety of autologous, mobilized, non-expanded CD133+ cells to treat Asherman´s Syndrome: A prospective, multi-center, phase I/II clinical trial. | |||||||||||||
Medical condition: Asherman's syndrome also known as intrauterine synechiae | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-006147-25 | Sponsor Protocol Number: UTEROXINE | Start Date*: 2022-11-15 | |||||||||||||||||||||||||||||||
Sponsor Name:Centre de Recherche en Santé de la Femme | |||||||||||||||||||||||||||||||||
Full Title: Botulinum toxin type A injection in patients with chronic pelvic pain of uterine origin (severe dysmenorrhea and/or deep dyspareunia). Phase III, single-center, randomized study vs. control group | |||||||||||||||||||||||||||||||||
Medical condition: PATIENTS WITH CHRONIC PELVIC PERINEAL PAIN OF UTERINE ORIGIN WITH VAS>4 | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000753-80 | Sponsor Protocol Number: 000298 | Start Date*: 2022-08-04 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, assessor-blind, active-controlled, parallel-group, dose-finding trial to investigate the efficacy and safety of FE 999302 for triggering of final follicular maturation in women underg... | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) CZ (Prematurely Ended) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002783-40 | Sponsor Protocol Number: 000304 | Start Date*: 2019-07-04 | |||||||||||||||||||||||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||||||||||||||||||||||
Full Title: A randomised, controlled, open label, parallel group, multicentre trial comparing the efficacy and safety of individualised FE 999049 (follitropin delta) dosing, using a long GnRH agonist protocol ... | |||||||||||||||||||||||||||||||||
Medical condition: Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||||||||||||
Trial protocol: AT (Completed) DK (Completed) NO (Completed) NL (Completed) IT (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-003227-38 | Sponsor Protocol Number: EMR700623_535 | Start Date*: 2013-03-07 | ||||||||||||||||
Sponsor Name:Merck Serono | ||||||||||||||||||
Full Title: A Multi-Centre, Two-Arm, Interventional, Phase IV Study to Evaluate Tailoring of Recombinant FSH Treatment in Subjects with Chronic Anovulation Using the Gonal-f® Prefilled Pen in Women Undergoing ... | ||||||||||||||||||
Medical condition: Anovulation in women with PCOS | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: GB (Completed) IE (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
